Oncology & Cancer
Researchers study tobacco use, cancer connection
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.
Oct 20, 2020
0
1
Renal Cell Carcinoma
Oncology & Cancer
Novel discovery challenges a current kidney cancer paradigm
Newly published research has reversed our understanding of an aspect of kidney tumor growth. Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered that two key proteins have opposite ...
Sep 12, 2020
0
10
Oncology & Cancer
Novel targeted drug induced positive response for VHL-associated kidney cancer
In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor (HIF)-2a was well tolerated and resulted ...
May 28, 2020
0
1
Medical research
US researchers collaborate with scientist quarantined in China during COVID-19 outbreak
Putting together research for publication can be a challenging and time-consuming process, heightened even further because of the current COVID-19 situation, during which non-essential labs have been hibernated and many researchers ...
Apr 20, 2020
0
2
Oncology & Cancer
Study shows cancers with high levels of the SLC7A11 gene may respond to glucose transporter inhibitor treatment
New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become "addicted" to glucose could open up fresh approaches to therapy strategies for cancers with high levels ...
Mar 30, 2020
0
90
Oncology & Cancer
Clinical trial exposes deadly kidney cancer's Achilles' heel
An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target. The finding from a team of researchers ...
Feb 20, 2020
0
30
Medical research
Novel drug targets tumor growth in advanced kidney cancer
Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease.
Feb 13, 2020
0
1
Oncology & Cancer
Researchers uncover new vulnerability in kidney cancer
A UT Southwestern researcher led a team that identified a new vulnerability in kidney tumors, the 10th most common cause of cancer death in men and women.
Jan 17, 2020
0
160
Oncology & Cancer
Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart
Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. ...
Dec 4, 2019
0
1
Medications
Favorable five-year survival reported for patients with advanced cancer treated with the immunotherapy
A research team led by experts at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center reports favorable five-year survival rates from the first multidose clinical trial of the ...
Jul 25, 2019
2
1276
